The main aim of this study is to investigate CA-125 and HE4 levels as the ovarian cancer markers and IL6 as a pro-inflammatory factor that contributes to the cell cycle and growth of ovarian cancer cells to predict tumor resectability in pre-operative patients with advanced epithelial ovarian cancer. Here, IL6 is linked to ovarian carcinoma.